Case reports
← vista completaPublished on November 26, 2015 | http://doi.org/10.5867/medwave.2015.10.6323
Intravenous immunoglobulin therapy in Morvan syndrome secondary to recurrent thymic carcinoma
Inmunoglobulina intravenosa en el tratamiento del síndrome de Morvan secundario a la recurrencia de un carcinoma tímico
Abstract
Morvan's syndrome is a rare autoimmune channelopathy. A case of Morvan's syndrome is presented as a paraneoplastic syndrome associated to the recurrence of a well-differentiated thymic carcinoma, which showed a good clinical response to treatment with intravenous immunoglobulin.